Clinical application of exosomes and circulating microRNAs in the diagnosis of pregnancy complications and foetal abnormalities

J Transl Med. 2020 Jan 22;18(1):32. doi: 10.1186/s12967-020-02227-w.

Abstract

During pregnancy in humans, the physiology of the mother and foetus are finely regulated by many factors. Inappropriate regulation can result in pregnancy disorders, such as complications and foetal abnormalities. The early prediction or accurate diagnosis of related diseases is a concern of researchers. Liquid biopsy can be analysed for circulating cells, cell-free nucleic acids, and exosomes. Because exosomes can be detected in the peripheral blood of women in early pregnancy, these vesicles and their contents have become the focus of early prediction or diagnostic biomarker research on pregnancy complications and foetal developmental disorders. In this review, we focus on recent studies addressing the roles of peripheral blood exosomes and circulating miRNAs in pregnancy complications and in pregnancies with abnormal foetal developmental disorders, with particular attention paid to the potential application value of exosomes and circulating miRNAs as disease-specific biomarkers.

Keywords: Exosomes; Foetal diseases; MicroRNAs; Pregnancy complications; Pregnant women.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Circulating MicroRNA*
  • Congenital Abnormalities* / diagnosis
  • Exosomes*
  • Female
  • Humans
  • Liquid Biopsy
  • MicroRNAs* / genetics
  • Pregnancy
  • Pregnancy Complications* / diagnosis
  • Pregnancy Complications* / genetics

Substances

  • Circulating MicroRNA
  • MicroRNAs